89 related articles for article (PubMed ID: 154798)
1. [Treatment of experimental immune complex nephritis with indomethacin].
Hagemann I; Schneider W; Philipp H; Strangfeld D; Siewert H; Tietze G; Pietsch R
Z Urol Nephrol; 1979 Jan; 72(1):49-58. PubMed ID: 154798
[TBL] [Abstract][Full Text] [Related]
2. Treatment of experimental immune complex glomerulonephritis by sodium alginate.
Mirshafiey A; Borzooy Z; Abhari RS; Razavi A; Tavangar M; Rehm BH
Vascul Pharmacol; 2005 Jun; 43(1):30-5. PubMed ID: 15893960
[TBL] [Abstract][Full Text] [Related]
3. Single and multiple drug therapy in autologous immune complex nephritis in rats.
Kupor LR; Lowance DC; McPhaul JJ
J Lab Clin Med; 1976 Jan; 87(1):27-36. PubMed ID: 128575
[TBL] [Abstract][Full Text] [Related]
4. The effect of protamine sulfate on the course of immune complex glomerulonephritis in the rat.
Oite T; Shimizu F; Batsford SR; Vogt A
Clin Exp Immunol; 1986 May; 64(2):318-22. PubMed ID: 2943540
[TBL] [Abstract][Full Text] [Related]
5. Influence of hypertension on the progression of experimental autologous immune complex nephritis.
Okuda S; Onoyama K; Fujimi S; Oh Y; Nomoto K; Omae T
J Lab Clin Med; 1983 Mar; 101(3):461-71. PubMed ID: 6219170
[TBL] [Abstract][Full Text] [Related]
6. Effect of the anticomplementary agent, K-76 monocarboxylic acid, on experimental immune complex glomerulonephritis in rats.
Iida H; Izumino K; Asaka M; Takata M; Mizumura Y; Sasayama S
Clin Exp Immunol; 1987 Jan; 67(1):130-4. PubMed ID: 3497741
[TBL] [Abstract][Full Text] [Related]
7. Effect of cyclosporine on in situ immune complex glomerulonephritis.
Thaiss F; Mihatsch MJ; Batsford S; Vogt A; Schollmeyer P
Clin Nephrol; 1986; 25 Suppl 1():S181-5. PubMed ID: 3519025
[TBL] [Abstract][Full Text] [Related]
8. Rat bovine serum albumin (BSA) nephritis. VI. The influence of chemically altered antigen.
Yamamoto T; Miyazaki S; Kawasaki K; Yaoita E; Kihara I
Clin Exp Immunol; 1986 Jul; 65(1):51-6. PubMed ID: 3539427
[TBL] [Abstract][Full Text] [Related]
9. Cyclosporin A prevents proteinuria in an active model of membranous nephropathy in rats.
Thaiss F; Schoeppe W; Willaredt-Stoll JG; Batsford S; Mihatsch MJ
Lab Invest; 1989 Dec; 61(6):661-9. PubMed ID: 2689773
[TBL] [Abstract][Full Text] [Related]
10. Treatment of rat nephrotoxic nephritis. Use of 5-fluorouracil or methotrexate-5-fluorouracil association.
de Almeida DB; Curi PR
Clin Exp Immunol; 1984 Sep; 57(3):591-9. PubMed ID: 6380837
[TBL] [Abstract][Full Text] [Related]
11. The heterologous immune complex glomerulonephritis. A dose dependent glomerulonephritis with acute, latent and chronic phases in a long-term study.
Iversen BM; Matre R; Ofstad J
Acta Pathol Microbiol Immunol Scand C; 1982 Oct; 90(5):241-50. PubMed ID: 6217719
[TBL] [Abstract][Full Text] [Related]
12. Expression and activation of STAT3 in chronic proliferative immune complex glomerulonephritis and the effect of fosinopril.
Zhang W; Chen X; Shi S; Wei R; Wang J; Yamanaka N; Hong Q
Nephrol Dial Transplant; 2005 May; 20(5):892-901. PubMed ID: 15755760
[TBL] [Abstract][Full Text] [Related]
13. Effects of a thromboxane synthetase inhibitor on established immune complex glomerulonephritis in dogs.
Grauer GF; Frisbie DD; Longhofer SL; Cooley AJ
Am J Vet Res; 1992 May; 53(5):808-13. PubMed ID: 1388004
[TBL] [Abstract][Full Text] [Related]
14. Low-dose local kidney irradiation inhibits progression of experimental crescentic nephritis by promoting apoptosis.
Liu D; Nazneen A; Taguchi T; Razzaque MS
Am J Nephrol; 2008; 28(4):555-68. PubMed ID: 18239382
[TBL] [Abstract][Full Text] [Related]
15. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
Marsman D
Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
[TBL] [Abstract][Full Text] [Related]
16. Bovine serum albumin (BSA) nephritis in rats. III. Antigen distribution in various organs.
Miyazaki S; Kawasaki K; Yaoita E; Yamamoto T; Kihara I
Clin Exp Immunol; 1985 Feb; 59(2):293-9. PubMed ID: 3884196
[TBL] [Abstract][Full Text] [Related]
17. [Immunopathological bases of the treatment of glomerulonephritis].
Vercellone A; Segoloni G; Stratta P; Coppo R; Triolo G; Messina M
Minerva Med; 1978 Aug; 69(38):2611-24. PubMed ID: 152419
[No Abstract] [Full Text] [Related]
18. Receptor antagonist of platelet activating factor inhibits inflammatory injury induced by in situ formation of immune complexes in renal glomeruli and in the skin.
Camussi G; Pawlowski I; Saunders R; Brentjens J; Andres G
J Lab Clin Med; 1987 Aug; 110(2):196-206. PubMed ID: 2955066
[TBL] [Abstract][Full Text] [Related]
19. Pentoxifylline suppresses renal tumour necrosis factor-alpha and ameliorates experimental crescentic glomerulonephritis in rats.
Chen YM; Ng YY; Lin SL; Chiang WC; Lan HY; Tsai TJ
Nephrol Dial Transplant; 2004 May; 19(5):1106-15. PubMed ID: 14993492
[TBL] [Abstract][Full Text] [Related]
20. Antibodies to glycolipids activate complement and promote proteinuria in passive Heymann nephritis.
Susani M; Schulze M; Exner M; Kerjaschki D
Am J Pathol; 1994 Apr; 144(4):807-19. PubMed ID: 8160779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
